Literature DB >> 15579444

Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice.

Rima Elhage1, Pierre Gourdy, Laurent Brouchet, Jacek Jawien, Marie-José Fouque, Catherine Fiévet, Xavier Huc, Yara Barreira, Jean Claude Couloumiers, Jean-François Arnal, Francis Bayard.   

Abstract

Recent studies have demonstrated the importance of lymphocytes, especially CD4(+) T cells, in early lesions of atherosclerosis in hypercholesterolemic mice. However, the role of other T cell subpopulations, like CD8(+) T cells or TCR gamma delta T lymphocytes, is not yet clear. We have therefore generated apolipoprotein E-deficient mice genetically deficient in specific T lymphocyte subpopulations and measured atherosclerotic lesions in the aortic sinus and en face whole aorta preparation at 18 weeks and at 1 year of age. Whereas TCR gamma delta(+) T lymphocytes appeared to play a modest role, TCR alpha beta(+) T lymphocytes played a major role as their deficiency significantly prevented early and late atherosclerosis at all arterial sites. However, neither CD4(+) nor CD8(+) T cells induced any significant decrease of the lesions at the aortic sinus, suggesting that compensatory proatherogenic mechanisms are operating at this site. Interestingly, the absence of CD4(+) T cells led to a dramatic increase in early lesion abundance at the level of the descending thoracic and abdominal aorta, which was still obvious at 1 year. In conclusion, whereas the TCR alpha beta(+) lymphocyte subset in its whole contribute to aggravate both early and late atherosclerosis, the CD4(+) T subpopulation appears to be critically protective at the level of the lower part of the aorta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579444      PMCID: PMC1618721          DOI: 10.1016/s0002-9440(10)63252-x

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

Review 1.  Innate and acquired immunity in atherogenesis.

Authors:  Christoph J Binder; Mi-Kyung Chang; Peter X Shaw; Yury I Miller; Karsten Hartvigsen; Asheesh Dewan; Joseph L Witztum
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Authors:  Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

3.  Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.

Authors:  Giuseppina Caligiuri; Antonino Nicoletti; Bruno Poirier; Göran K Hansson
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

4.  B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice.

Authors:  Amy S Major; Sergio Fazio; MacRae F Linton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

5.  Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice.

Authors:  Hélène Duez; Yu-Sheng Chao; Melba Hernandez; Gérard Torpier; Philippe Poulain; Steven Mundt; Ziad Mallat; Elisabeth Teissier; Charlotte A Burton; Alain Tedgui; Jean-Charles Fruchart; Catherine Fiévet; Sam D Wright; Bart Staels
Journal:  J Biol Chem       Date:  2002-10-10       Impact factor: 5.157

Review 6.  Inflammation and atherosclerosis.

Authors:  Peter Libby; Paul M Ridker; Attilio Maseri
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

7.  Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection.

Authors:  Devon J Shedlock; Jason K Whitmire; Joyce Tan; Andrew S MacDonald; Rafi Ahmed; Hao Shen
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

8.  Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.

Authors:  Ziad Mallat; Andrea Gojova; Valérie Brun; Bruno Esposito; Nathalie Fournier; Françoise Cottrez; Alain Tedgui; Hervé Groux
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

9.  The inter-relatedness and interdependence of mouse T cell receptor gammadelta+ and alphabeta+ cells.

Authors:  Daniel J Pennington; Bruno Silva-Santos; John Shires; Efstathios Theodoridis; Christopher Pollitt; Emma L Wise; Robert E Tigelaar; Michael J Owen; Adrian C Hayday
Journal:  Nat Immunol       Date:  2003-09-21       Impact factor: 25.606

10.  Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe.

Authors:  Catherine A Reardon; Lydia Blachowicz; John Lukens; Michael Nissenbaum; Godfrey S Getz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-06-05       Impact factor: 8.311

View more
  35 in total

Review 1.  Interleukin 17 in vascular inflammation.

Authors:  Sibylle von Vietinghoff; Klaus Ley
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

Review 2.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Adaptive immunity in atherogenesis: new insights and therapeutic approaches.

Authors:  Andrew H Lichtman; Christoph J Binder; Sotirios Tsimikas; Joseph L Witztum
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 4.  Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.

Authors:  Charlotte Spitz; Holger Winkels; Christina Bürger; Christian Weber; Esther Lutgens; Göran K Hansson; Norbert Gerdes
Journal:  Cell Mol Life Sci       Date:  2015-10-30       Impact factor: 9.261

Review 5.  Animal models of atherosclerosis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

6.  The atheroprotective effect of 17beta-estradiol depends on complex interactions in adaptive immunity.

Authors:  Rima Elhage; Pierre Gourdy; Jacek Jawien; Laurent Brouchet; Caroine Castano; Catherine Fievet; Göran K Hansson; Jean-François Arnal; Francis Bayard
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

Review 7.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

Review 8.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

Review 9.  Adaptive immunity and atherosclerosis: mouse tales in the AJP.

Authors:  Andrew H Lichtman
Journal:  Am J Pathol       Date:  2012-11-16       Impact factor: 4.307

10.  Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-/- mice.

Authors:  Jennifer A Cann; Thomas C Register; Michael R Adams; Richard W St Clair; Mark A Espeland; J Koudy Williams
Journal:  Atherosclerosis       Date:  2008-02-21       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.